EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Revisiting Lymph Node Staging in the 9th TNM Classification for Lung Cancer: A Bronchoscopic Perspective

Judith Maria Brock, Felix J F Herth

Respiration · 2025

DOI: 10.1159/000548344 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Respiration, 2025. Verfasst von Judith Maria Brock und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pneumology and Critical Care Medicine, Thoraxklinik, University of Heidelberg and Translational Lung Research Center Heidelberg (TLRCH)…. Hauptthemen laut MEDLINE: Lung Neoplasms, Neoplasm Staging, Bronchoscopy, Lymph Nodes. Die Arbeit nennt 50 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background: The TNM staging system is the cornerstone of lung cancer classification, providing a framework for prognosis and treatment planning in a universal nomenclature. The 9th edition of the TNM classification, released by the International Association for the Study of Lung Cancer (IASLC) and went into effect in January 2025, introduces refinements to lymph node (N) staging. Lymph node staging is performed minimally invasively using bronchoscopy with endobronchial ultrasound (EBUS). This article explores the latest updates on lymph node staging by EBUS and their implications for lung cancer management from the perspective of bronchoscopy. Summary: The 9th edition of the TNM classification includes the subdivision of N2 lymph nodes into N2a single-station and N2b multiple-station involvement, but not the subdivision of N1 lymph nodes. This has implications not only for treatment but also for the number of lymph nodes sampled by EBUS. As there is no strict hierarchy of N2 lymph nodes, this poses challenges to the order in which N2 lymph nodes should be sampled. The development of a new thin EBUS device will enable sampling of peripheral N1 lymph nodes. This could influence future TNM classifications, given that there are pathological but not clinical differences in survival between purely peripheral and hilar N1 involvement. Key Messages: With respect to occult lymph node disease, EBUS remains fundamental in staging lung cancer. New technical developments will also enable sampling of peripheral N1 lymph nodes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsNeoplasm StagingBronchoscopyLymph NodesHumansLymphatic MetastasisEndosonography

Stichwörter der Autor:innen

BronchoscopyEndobronchial ultrasoundLung cancerLymph node stagingTNM

Autor:innen und Institutionen

  • Department of Pneumology and Critical Care Medicine, Thoraxklinik, University of Heidelberg and Translational Lung Research Center Heidelberg (TLRCH), German Center of Lung Disease (DZL), Heidelberg, Germany, judith.bro…
  • Department of Pneumology and Critical Care Medicine, Thoraxklinik, University of Heidelberg and Translational Lung Research Center Heidelberg (TLRCH), German Center of Lung Disease (DZL), Heidelberg, Germany.

Zitieren

APA

Brock, J. M., & Herth, F. J. F. (2025). Revisiting Lymph Node Staging in the 9th TNM Classification for Lung Cancer: A Bronchoscopic Perspective. Respiration. https://doi.org/10.1159/000548344

Vancouver

Brock JM, Herth FJF. Revisiting Lymph Node Staging in the 9th TNM Classification for Lung Cancer: A Bronchoscopic Perspective. Respiration. 2025. doi:10.1159/000548344

BibTeX
@article{Brock2025,
  author = {Brock, Judith Maria and Herth, Felix J F},
  title = {Revisiting Lymph Node Staging in the 9th TNM Classification for Lung Cancer: A Bronchoscopic Perspective},
  journal = {Respiration},
  year = {2025},
  doi = {10.1159/000548344}
}
Kostenlos starten →